Q&A: As RSV vaccine approvals loom, regulators need to devise vaccination strategies
Sachiko Ozawa, a health economist, discusses nuances of vaccine launch strategies, as PDUFA dates for two RSV vaccines for older adults near the horizon.
Interviews
Q&A: A decade on, what’s next for CAR-T therapies?
Q&A: Cleaning up the antibiotic resistance problem in dentistry
Biosimilar Q&A: Is an interchangeability designation still relevant?
Why moving from Europe to Charleston SC to work in medtech was a win-win for me and my family
Life science recruitment expert explains how Charleston is attracting top talent from across the globe
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox